Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

ROCCA, BIANCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.063
AS - Asia 3.724
SA - Sud America 2.439
EU - Europa 855
AF - Africa 381
Continente sconosciuto - Info sul continente non disponibili 255
OC - Oceania 9
Totale 11.726
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.792
BR - Brasile 1.899
SG - Singapore 1.103
VN - Vietnam 1.038
CN - Cina 887
MA - Marocco 251
IT - Italia 243
AR - Argentina 221
HK - Hong Kong 169
DE - Germania 144
ID - Indonesia 137
EC - Ecuador 115
CA - Canada 104
BD - Bangladesh 97
PK - Pakistan 90
GB - Regno Unito 83
MX - Messico 75
FR - Francia 69
RU - Federazione Russa 67
IN - India 63
CO - Colombia 62
ZA - Sudafrica 48
PY - Paraguay 43
AT - Austria 42
CL - Cile 31
NL - Olanda 30
FI - Finlandia 28
ES - Italia 26
VE - Venezuela 25
CR - Costa Rica 24
UA - Ucraina 22
PE - Perù 21
EG - Egitto 20
IQ - Iraq 16
PL - Polonia 16
DZ - Algeria 15
JP - Giappone 15
KE - Kenya 15
BG - Bulgaria 13
TR - Turchia 13
TN - Tunisia 12
UY - Uruguay 12
DO - Repubblica Dominicana 11
PH - Filippine 11
UZ - Uzbekistan 11
KZ - Kazakistan 10
SV - El Salvador 10
BO - Bolivia 9
GT - Guatemala 9
HN - Honduras 9
SA - Arabia Saudita 9
AL - Albania 8
AU - Australia 8
JM - Giamaica 8
EE - Estonia 7
SE - Svezia 7
KR - Corea 6
MD - Moldavia 6
MY - Malesia 6
AZ - Azerbaigian 5
CU - Cuba 5
IE - Irlanda 5
PA - Panama 5
PT - Portogallo 5
RO - Romania 5
SN - Senegal 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
IL - Israele 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
BH - Bahrain 3
CG - Congo 3
CH - Svizzera 3
JO - Giordania 3
KW - Kuwait 3
MK - Macedonia 3
PS - Palestinian Territory 3
RS - Serbia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
ET - Etiopia 2
KG - Kirghizistan 2
KH - Cambogia 2
LT - Lituania 2
OM - Oman 2
PR - Porto Rico 2
BF - Burkina Faso 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
Totale 11.454
Salva come PNG Salva come JPEG
Città #
Dallas 1.255
Singapore 558
Ho Chi Minh City 400
Ashburn 358
San Jose 280
The Dalles 261
Hefei 228
Casablanca 225
Hanoi 196
San Francisco 175
Hong Kong 164
São Paulo 160
Beijing 142
Santa Clara 96
New York 92
Islamabad 71
Columbus 68
Los Angeles 63
Rio de Janeiro 55
Council Bluffs 53
Haiphong 48
Rome 43
Chardon 41
Frankfurt am Main 41
Guayaquil 41
Da Nang 38
Chicago 37
Curitiba 37
Milan 36
Phoenix 33
Brasília 32
Munich 31
Belo Horizonte 30
Quito 30
Biên Hòa 29
Orem 25
Thái Bình 24
Helsinki 23
Hải Dương 22
Porto Alegre 22
Montreal 21
Toronto 21
Buenos Aires 20
Campinas 20
Ninh Bình 20
Mexico City 19
Naples 19
Jakarta 18
Piracicaba 18
Amsterdam 17
Asunción 17
Barnet 17
Brooklyn 17
Ha Long 17
Johannesburg 17
Oxnard 17
Fortaleza 16
Guarulhos 16
Nuremberg 16
Atlanta 15
Chennai 15
North Bergen 15
San José 15
Sorocaba 15
Can Tho 14
Denver 14
Salvador 14
Vienna 14
Bắc Giang 13
São José do Rio Preto 13
Bogotá 12
Bắc Ninh 12
Cairo 12
Dhaka 12
London 12
Miami 12
Moscow 12
Nairobi 12
Thái Nguyên 12
Tokyo 12
Viamão 12
Boston 11
Hillsboro 11
Osasco 11
Phủ Lý 11
Recife 11
Ribeirão Preto 11
Bologna 10
Goiânia 10
Hortolândia 10
Montevideo 10
Philadelphia 10
Princeton 10
Rabat 10
San Salvador 10
Surabaya 10
Warsaw 10
Duque de Caxias 9
Durban 9
Itapevi 9
Totale 6.388
Salva come PNG Salva come JPEG
Nome #
Management of cancer-associated venous thromboembolism: Perspectives on optimizing current therapeutics with a focus on factor XI inhibition 278
Rethinking aspirin responsiveness in coronary surgery: True resistance or misinterpretation 200
2025 ESC/EACTS Guidelines for the management of valvular heart disease 195
2025 ESC/EACTS Guidelines for the management of valvular heart disease 178
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 129
Cardio-oncology: Emerging Concepts in Cardiovascular Sequelae of Cancer Therapies, Translational Research and Reverse Cardio-oncology 117
2024 EACTS Guidelines on perioperative medication in adult cardiac surgery 94
Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects 93
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases 90
Prolonged fasting promotes systemic inflammation and platelet activation in humans: A medically supervised, water-only fasting and refeeding study 90
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy 88
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 87
2024 EACTS guidelines on perioperative medication in adult cardiac surgery: embracing precision medicine driven by strong evidence-based methodology 79
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 78
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer 78
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 77
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 75
2023 ESC Guidelines for the management of acute coronary syndromes 74
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes 72
Aspirin, stroke and drug-drug interactions 70
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 70
Acceptability of aspirin for cancer preventive therapy: a survey and qualitative study exploring the views of the UK general population 68
A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation 66
Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH 66
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 65
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes 65
Management of dyslipidaemia in patients with comorbidities—facing the challenge: type 1 diabetes mellitus 64
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 64
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA) 64
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings 63
Polycythemia Vera: the natural history of 1213 patients followed for 20 years 62
Platelet reactivity in patients with stable cardiovascular disease using aspirin: correlation between different tests and association with subject characteristics 62
Infective Endocarditis and Antithrombotic Therapy 61
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: A joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA) 61
Prostaglandins and other eicosanoids 61
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 61
Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover study 60
A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation 60
Reprogramming Epigenetic Changes Blunts p66Shc-induced Vascular Dysfunction In Experimental and Human Obesity: Insights for Mechanisms-Based Therapeutic Strategies 60
Increased Von Willebrand Factor levels in Polycythemia Vera and phenotypic differences with Essential Thrombocythemia 60
Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes 59
Abnormal Megakaryopoiesis and Platelet Function in Cyclooxygenase-2-Deficient Mice 59
Ticagrelor and Statins: Dangerous Liaisons? 58
Kinetics of free platelet decrease after ADP: effect of fibrinogen binding inhibitors 58
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC 58
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis 57
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 57
Characterization of aspirin esterase activity in health and disease: In vitro and ex vivo studies 57
Platelet and megakaryocyte phenotypes of COX-2 deletion 57
Update on antithrombotic therapy and body mass. A Clinical consensus Statement of the ESC Working Group on Cardiovascular Pharmacotherapy and the ESC Working Group on Thrombosis 56
Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B2 and 8-iso-prostaglandin F2α, levels in human urine samples by validated enzyme immunoassays 56
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 56
EQUIVALENZE DI CLASSE TE RAPEUTICA NELL'AREA DEGLI ANTICOAGULANTI ORALI 56
In Vivo Platelet Activation in Impaired Glucose Tolerance and During Progression of Type 2 Diabetes: a Cross-sectional and Longitudinal Study 56
The lifespan determinant p66shc drives obesity-induced oxidative stress, mitochondrial dysfunction and vascular inflammation 55
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer 55
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome 55
Heat extremes and cardiovascular diseases: a scientific statement of the Association of Cardiovascular Nursing & Allied Professions, Association for Acute Cardiovascular Care, European Association of Preventive Cardiology, Heart Failure Association, European Heart Rhythm Association of the ESC, the ESC Council on Hypertension, the ESC Council on Stroke, and the ESC Working Group on Cardiovascular Pharmacotherapy 55
Characterization of aspirin esterase activity in health and disease: In vitro and ex vivo studies 55
Factor XI and Atrial Fibrillation: A Mismatched Pairing? 54
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 54
Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspective 54
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design - implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting. (Rocca B and De Stefano V co-first Authors) 53
Platelet progenitors: the hidden drug target 53
Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus 53
Antithrombotic therapy and revascularisation strategies in people with diabetes and coronary artery disease 53
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 53
Twice Daily Dosing Normalyzes the Impaired Antiplatelet Effect of Low-Dose Aspirin Due to Enhanced Platelet Turnover in Patients Undergoing On-Pump Cardiac Surgery 53
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia 53
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 53
Clinical guidelines for a dry land: challenges in developing recommendations for DOAC management in emergent cardiac surgery 52
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing 52
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume 52
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial 52
Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation 51
Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Acute Cardiovascular Care Association (ACCA), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS) 51
In Silico Modeling of the Antiplatelet Pharmacodynamics of Low-dose Aspirin in Health and Disease 51
Aspirin for primary prevention: new scores for old questions? 51
Effect of low-dose and standard-dose aspirin on PGE2 biosynthesis among individuals with colorectal adenomas: A randomized clinical trial 50
Nonsteroidal Antiinflammatory Drugs: Past, Present and Future 50
The ESC Working Group on Cardiovascular Pharmacotherapy: continuity through transformation 50
The Key Contribution Of Platelet And Vascular Arachidonic Acid Metabolism To The Pathophysiology Of Atherothrombosis 49
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a Joint Position Paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) 49
Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents 49
Farmaci antipiastrinici 49
Genetic Deletion of P66 (Shc) Protects Against Obesity-Induced Mitochondrial Dysfunction, Oxidative Stress and Vascular Inflammation 49
Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis 48
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 48
Thromboxane biosynthesis and future events in diabetes: the ASCEND trial 48
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis 48
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis 48
Low-dose aspirin in polycythaemia vera: A pilot study 48
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 47
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome 47
In vivo platelet activation and aspirin responsiveness in type 1 diabetes mellitus 47
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector 46
Pathophysiology of Thrombosis in Peripheral Artery Disease 46
Linee guida ESC 2023 per il trattamento delle malattie cardiovascolari nei pazienti diabetici 46
Cyclooxygenase-2 expression is induced during megakaryopoiesis and characterizes newly formed platelets 45
Less thromboxane, longer life 45
Totale 6.630
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.612
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.362 0 0 0 343 104 91 22 52 199 166 236 149
2025/20268.889 242 1.074 1.894 2.978 171 120 641 519 396 562 191 101
2026/20271.475 142 168 368 797 0 0 0 0 0 0 0 0
Totale 11.726